Return to study ST001024 main page

Download data matrix(TCA cycle metabolomics of H3K27M cells grown in regular glutamine media, glutamine free media, and glutamine free media with alpha-ketoglutarate (Part-II) GC POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
GC POSITIVE ION MODESample # 1Sample type:Cells | Grouping:IV Controlnmol/vial
GC POSITIVE ION MODESample # 2Sample type:Cells | Grouping:IV Controlnmol/vial
GC POSITIVE ION MODESample # 3Sample type:Cells | Grouping:IV Controlnmol/vial
GC POSITIVE ION MODESample # 7Sample type:Cells | Grouping:IV Treatment 1nmol/vial
GC POSITIVE ION MODESample # 8Sample type:Cells | Grouping:IV Treatment 1nmol/vial
GC POSITIVE ION MODESample # 9Sample type:Cells | Grouping:IV Treatment 1nmol/vial
GC POSITIVE ION MODESample # 13Sample type:Cells | Grouping:IV Treatment 2nmol/vial
GC POSITIVE ION MODESample # 14Sample type:Cells | Grouping:IV Treatment 2nmol/vial
GC POSITIVE ION MODESample # 15Sample type:Cells | Grouping:IV Treatment 2nmol/vial
GC POSITIVE ION MODESample # 19Sample type:Cells | Grouping:XVII Controlnmol/vial
GC POSITIVE ION MODESample # 20Sample type:Cells | Grouping:XVII Controlnmol/vial
GC POSITIVE ION MODESample # 21Sample type:Cells | Grouping:XVII Controlnmol/vial
GC POSITIVE ION MODESample # 25Sample type:Cells | Grouping:XVII Treatment 1nmol/vial
GC POSITIVE ION MODESample # 26Sample type:Cells | Grouping:XVII Treatment 1nmol/vial
GC POSITIVE ION MODESample # 27Sample type:Cells | Grouping:XVII Treatment 1nmol/vial
GC POSITIVE ION MODESample # 31Sample type:Cells | Grouping:XVII Treatment 2nmol/vial
GC POSITIVE ION MODESample # 32Sample type:Cells | Grouping:XVII Treatment 2nmol/vial
GC POSITIVE ION MODESample # 33Sample type:Cells | Grouping:XVII Treatment 2nmol/vial
GC POSITIVE ION MODESample # 4Sample type:Media | Grouping:IV Controlnmol/vial
GC POSITIVE ION MODESample # 5Sample type:Media | Grouping:IV Controlnmol/vial
GC POSITIVE ION MODESample # 6Sample type:Media | Grouping:IV Controlnmol/vial
GC POSITIVE ION MODESample # 10Sample type:Media | Grouping:IV Treatment 1nmol/vial
GC POSITIVE ION MODESample # 11Sample type:Media | Grouping:IV Treatment 1nmol/vial
GC POSITIVE ION MODESample # 12Sample type:Media | Grouping:IV Treatment 1nmol/vial
GC POSITIVE ION MODESample # 16Sample type:Media | Grouping:IV Treatment 2nmol/vial
GC POSITIVE ION MODESample # 17Sample type:Media | Grouping:IV Treatment 2nmol/vial
GC POSITIVE ION MODESample # 18Sample type:Media | Grouping:IV Treatment 2nmol/vial
GC POSITIVE ION MODESample # 22Sample type:Media | Grouping:XVII Controlnmol/vial
GC POSITIVE ION MODESample # 23Sample type:Media | Grouping:XVII Controlnmol/vial
GC POSITIVE ION MODESample # 24Sample type:Media | Grouping:XVII Controlnmol/vial
GC POSITIVE ION MODESample # 28Sample type:Media | Grouping:XVII Treatment 1nmol/vial
GC POSITIVE ION MODESample # 29Sample type:Media | Grouping:XVII Treatment 1nmol/vial
GC POSITIVE ION MODESample # 30Sample type:Media | Grouping:XVII Treatment 1nmol/vial
GC POSITIVE ION MODESample # 34Sample type:Media | Grouping:XVII Treatment 2nmol/vial
GC POSITIVE ION MODESample # 35Sample type:Media | Grouping:XVII Treatment 2nmol/vial
GC POSITIVE ION MODESample # 36Sample type:Media | Grouping:XVII Treatment 2nmol/vial
  logo